Adenosine receptor (e.g., A2A and/or A1 receptor) antagonist compounds and compositions including said compounds are disclosed. The present disclosure also provides methods of using said compounds and compositions for modulating (e.g., inhibiting or antagonizing) A2A and/or A1 receptor in a biological system. The compounds and compositions find use in various therapeutic applications including the treatment of central nervous system or neurodegenerative diseases, such as Parkinson's disease. The compounds and compositions may also find use in various therapeutic applications including the treatment of cancer and in immuno-oncology.
本文揭示了
腺苷受体(如A2A和/或A1受体)
拮抗剂化合物和包括这些化合物的组合物。本文还提供了使用这些化合物和组合物在
生物系统中调节(如抑制或拮抗)A2A和/或A1受体的方法。这些化合物和组合物可用于各种治疗应用,包括治疗中枢神经系统或神经退行性疾病,如帕
金森病。这些化合物和组合物还可用于各种治疗应用,包括癌症治疗和免疫肿瘤学。